Matches in Wikidata for { <http://www.wikidata.org/entity/Q92759662> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q92759662 description "article scientifique publié en 2020" @default.
- Q92759662 description "articolo scientifico (pubblicato il 2020)" @default.
- Q92759662 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q92759662 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92759662 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92759662 description "scientific article published on 01 January 2020" @default.
- Q92759662 description "wetenschappelijk artikel" @default.
- Q92759662 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q92759662 description "научна статия" @default.
- Q92759662 name "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 name "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 name "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 type Item @default.
- Q92759662 label "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 label "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 label "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 prefLabel "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 prefLabel "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 prefLabel "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 P1433 Q92759662-82F21B9B-23B3-4983-8F1C-8B5147C680C9 @default.
- Q92759662 P1476 Q92759662-F854EF22-B9D9-4FDF-B474-F08D9A49A522 @default.
- Q92759662 P2093 Q92759662-10B748A7-7192-4619-93BB-A6446A70972E @default.
- Q92759662 P2093 Q92759662-844FCB58-A868-4E31-901B-6F023F6A7B1B @default.
- Q92759662 P2093 Q92759662-C99DDC46-68DC-48AD-A52D-A82D3D6A0DF4 @default.
- Q92759662 P2093 Q92759662-D14EBB5E-8E35-4BAB-AA86-B2C23EA24149 @default.
- Q92759662 P2093 Q92759662-D513D3F8-0A08-4D4E-B77F-A85B5F186F11 @default.
- Q92759662 P275 Q92759662-f22f44d2-9bd8-43fc-87b0-76951f4682e5 @default.
- Q92759662 P2860 Q92759662-585ABDDB-7641-4AF5-A68A-49EC20C9E3F8 @default.
- Q92759662 P2860 Q92759662-5CBBA453-2E2F-4851-B4D3-7AE6C9B0BEAC @default.
- Q92759662 P2860 Q92759662-72E85267-BE9E-4745-ACB8-D376F2829AE8 @default.
- Q92759662 P2860 Q92759662-7332A3F1-46B2-4DA1-A03A-B84041045881 @default.
- Q92759662 P2860 Q92759662-C9E4BD94-9F6B-432E-8889-6271F41574AB @default.
- Q92759662 P2860 Q92759662-E9EECB7C-87EE-4B98-9733-CF7A87C8228E @default.
- Q92759662 P304 Q92759662-29BFFD77-FA9B-4CDA-98D0-521989893949 @default.
- Q92759662 P31 Q92759662-5C55C023-F941-4DCF-929B-9F1F840CC72A @default.
- Q92759662 P356 Q92759662-C02721AB-F262-41CF-9600-B8EA6310B23F @default.
- Q92759662 P433 Q92759662-CC75E986-5A18-48D1-96C2-8F40DECF356D @default.
- Q92759662 P478 Q92759662-63FCB124-DD65-4290-B423-B36303DB3B80 @default.
- Q92759662 P577 Q92759662-6FCDD97D-4203-4E97-A465-EB58703674AB @default.
- Q92759662 P6216 Q92759662-b9fd348e-1b06-45b3-b967-b6c0267861c8 @default.
- Q92759662 P698 Q92759662-193477C5-FE61-4766-A97F-2A7282C3C75E @default.
- Q92759662 P921 Q92759662-70BB9181-8E8C-4C37-8E13-E75BBA1F60EF @default.
- Q92759662 P921 Q92759662-EF999369-3F45-4521-BEE6-9B30AD3377A5 @default.
- Q92759662 P932 Q92759662-B0F97083-CD27-406D-8237-0C86473567A8 @default.
- Q92759662 P356 SAJC.SAJC_157_19 @default.
- Q92759662 P698 31956609 @default.
- Q92759662 P1433 Q26842041 @default.
- Q92759662 P1476 "An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome" @default.
- Q92759662 P2093 "Amit Joshi" @default.
- Q92759662 P2093 "Kumar Prabhash" @default.
- Q92759662 P2093 "Vanita Noronha" @default.
- Q92759662 P2093 "Vijay Patil" @default.
- Q92759662 P2093 "Vikas T Talreja" @default.
- Q92759662 P275 Q24082749 @default.
- Q92759662 P2860 Q26850125 @default.
- Q92759662 P2860 Q26852274 @default.
- Q92759662 P2860 Q33161027 @default.
- Q92759662 P2860 Q44846367 @default.
- Q92759662 P2860 Q56807699 @default.
- Q92759662 P2860 Q90320698 @default.
- Q92759662 P304 "6" @default.
- Q92759662 P31 Q13442814 @default.
- Q92759662 P356 "10.4103/SAJC.SAJC_157_19" @default.
- Q92759662 P433 "1" @default.
- Q92759662 P478 "9" @default.
- Q92759662 P577 "2020-01-01T00:00:00Z" @default.
- Q92759662 P6216 Q50423863 @default.
- Q92759662 P698 "31956609" @default.
- Q92759662 P921 Q3658562 @default.
- Q92759662 P921 Q7083106 @default.
- Q92759662 P932 "6956583" @default.